What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Management of Raynaud’s Phenomenon

John D. Pauling

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Department of Allergy & Immunology

P. Grayson

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

APOL1 Controversies Conference Plenary: APOL1 Pathophysiology

KDIGO

D. Friedman

New Approaches to the Treatment of IgA Nephropathy

Leicester IgA Nephropathy

J. Barratt

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

Social Determinants of Health for Cardiovascular Kidney Metabolic Sy…

Kibret Enyew Belay

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

Updates on IgA Nephropathy - Part 2

KDIGO

J. Floege

Peritoneal Dialysis in ADPKD

Columbia University

S. Shirazian

Interview with IgA Nephropathy Patient Alistair

Leicester IgA Nephropathy

L. Iga Nephropathy

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Treatment of Fabry Disease

Ankit Mehta

Multivitamins and Health: What Do We Know?

Joanne Manson

Regenerating Kidney Tissue to Combat Nephropathic Cystinosis

Benjamin Freedman